We studied the impact of promoter hypermethylation of genes involved in the RASSF/Hippo pathway, namely RASSF1/2, STK4/3, and LATS1/2, by studying their methylation status by MS-PCR in a retrospective CRC cohort. This evidence concerns the gene RASSF1 and colorectal carcinoma.